Virinchi Hospitals collaborates with MedGenome for Molecular Diagnostics

Hyderabad, November 21, 2017: Virinchi Hospitals, a subsidiary of Hyderabad-based listed IT Company, Virinchi Ltd has entered into a strategic collaboration with MedGenome, a genomics based diagnostics and research company for molecular diagnostics.
As an outcome of this alliance, Virinchi will be able to offer a range of MedGenome's genetic tests concerned with various specialities including but not limited to cardiology, ophthalmology, oncology, neurology, nephrology, diabetes, dermatology, haematology, connective tissue and metabolic disorders to their patients with enhanced precision in order to provide most suitable and personalised care across all age groups and genders belonging to diverse geographical origins. In addition to these, non-invasive prenatal test will also be available which will help the would-be parents to know about the genetic health of their baby from a simple blood prick from the mother.
Speaking on the inauguration, Dr. Chirantan Bose, Vice-President, Clinical Services, MedGenome, said, “MedGenome is looking forward to this partnership for bringing affordable and high quality genetic testing to the patients of Virinchi hospitals. India has a huge burden of genetic disorders and it is imperative to embrace genomic solutions for the benefit of public at large. MedGenome’s continuous innovation is helping reduce the costs of previously expensive genetic tests, and empowering clinicians with actionable insights to provide better outcomes for their patients.”
MedGenome currently offers more than 400 genetic tests across key disease areas with a network of more than 500 hospitals for diagnostics and 50 plus research collaborations globally.
Commenting on the partnership, Dr. Murty Nekkanti, Medical Director, Virinchi Hospitals, said, “We are very pleased to collaborate with MedGenome to add value to the existing diagnostic portfolio and treatment outcomes. The aim of this collaboration is to help the clinician with molecular information for accurate as well as precise diagnosis, prognosis and management of multitude of diseases that have genetic basis. And, genetic testing has gradually been gaining prominence and significance in terms in effectively diagnosing & managing many rare to common diseases such as Spinal muscular atrophy, Huntington’s disease, and Inborn errors of metabolism. Our collaboration with partners like Medgenome shall certainly keep us in a favourable position to offer molecular testing services more competently to our patients.”
Mr. Sam Davala, Director of Scientific Affairs, Virinchi Hospitals, mentioned that “Virinchi Hospitals is striving towards promoting healthcare awareness and offering state of the art diagnostic, therapeutic and bigdata analytical services through experienced experts from relevant medical fields. And the traditional approach of one size fits for all in treatment, nutrition and fitness should transform with the help of genome wide diagnostics and drive us towards personalisation. I wish the message of specific diagnosis and health management is understood well by medical fraternity as well as commoners well enough to take benefit out of all the medical sciences advancements offered either through Virinchi or through its collaborations from across the globe.”